Nanocytology Test to Evaluate Skin Cancer in High Risk Patients

Completed · Not applicable

Conditions studied: Actinic Keratosis, Squamous Cell Carcinoma

In brief

The purpose of this study is to correlate pathological features from specimens in order to determine if this new molecular diagnostic technique can be used to detect risk of skin cancer.

Key facts

Study ID

NCT01905891

Run by

Northwestern University

People needed

7

Starts

2013-07-01

Expected to finish

2014-11-01

Last updated by the study team

2014-11-19

Who can join

Age: 18 and older, up to 89. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 18 to 89 years old, male and female, Fitzpatrick skin phototype I - III
• Photodamage skin grades 3 - 4 (global assessment)
• Medical history of precancerous lesions and or known history of SCC or healthy volunteers

You may not qualify if…

• Subjects under 18 years old
• Pregnant women or lactating mothers
• Treatment with systemic chemotherapy within 4 weeks period before consent
• Known HIV+ patients (self-reported)

Where it is running

• Northwestern Memorial Hospital — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.